For profit Phase 3
Founded: San Antonio TX United States (1992)
Status: Acquired by Genzyme (2004) → now Sanofi-Aventis (2011)

Organization Overview

First Clinical Trial
1996
NCT00002911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1996

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ILEX Oncology | ILEX Oncology Services, Incorporated